Podcast interview
Infectious diseases research in Indonesia
Clinical Infectious Diseases research at OUCRU Indonesia addresses prevention, diagnosis and management of complex infectious diseases, focusing on tuberculosis, HIV, and antimicrobial resistance, and other emerging infections. Participation in the RECOVERY trial contributed to the identification of four treatments for severe COVID-19. We are building research expertise and prioritize translating research findings into policy. Our goal is to reduce disease burdens through technical and implementation innovations.
Raph Hamers
MD PhD
Associate Professor in Infectious Diseases
- Interim Director of the Oxford University Clinical Research Unit (OUCRU) Indonesia
- Head of Clinical Infectious Diseases Research Programme, OUCRU Indonesia
- Associate Professor in Infectious Diseases, Nuffield Dept of Medicine, University of Oxford
- Consultant in Internal Medicine and Infectious Diseases
Oxford University Clinical Research Unit (OUCRU) Indonesia
Raph Hamers is the Interim Director of the Oxford University Clinical Research Unit (OUCRU) Indonesia, and also leads its Clinical Infectious Disease Research Programme. He is also an Associate Professor at the University of Oxford's Nuffield Department of Medicine, and an Adjunct Professor at the Faculty of Medicine Universitas Indonesia.
Following his PhD in Medicine at the University of Amsterdam, he was the recipient of a Veni career development fellowship through the Dutch Research Council (NWO) Talent Programme. He also contributes his expertise as an honorary consultant internist and infectious disease physician at the Amsterdam University Medical Centres, and as a consultant for the Antimicrobial Resistance Division at the World Health Organization.
Since 2017, he has spearheaded establishing the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL), embedded in the Faculty of Medicine Universitas Indonesia, in central Jakarta. This research hub aims to strengthen clinical research, training and community engagement capabilities through collaboration with OUCRU Indonesia’s primary partners and the Oxford Tropical Network.
Prof. Hamers' research is wide-ranging across several global health challenges, with a focus on improving health outcomes of complex infectious diseases in low and middle income countries. He has extensive experience as a lead investigator of clinical trials and connected epidemiological, social and laboratory science studies in sub-Saharan Africa and Southeast Asia. His research focuses on antimicrobial resistance and stewardship, prevention and management of HIV, the clinical management of tuberculosis, and other emerging infectious diseases relevant to Indonesia and the region.
He has received funding from the Medical Research Council-UK Research and Innovation (UKRI), Wellcome Trust, US Centre for Disease Prevention and Control, Oxford University, WHO, Dutch Research Council, the Dutch AidsFonds, and other agencies.
Recent publications
-
Research Electronic Data Capture (REDCap) for Population-Based Data Collection in Low- and Middle-Income Countries: Opportunities, Challenges, and Solutions.
Le HT. et al, (2025), J Med Internet Res, 27
-
Identifying context-specific determinants to inform improvement of antimicrobial stewardship implementation in healthcare facilities in Asia: results from a scoping review and web-based survey among local experts.
Limato R. et al, (2025), BMJ open quality, 14
-
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.
Poolchanuan P. et al, (2025), Scientific reports, 15
-
Incorporating acute HIV infection screening, same‐day diagnosis and antiretroviral treatment into routine services for key populations at sexual health clinics in Indonesia: a baseline analysis of the INTERACT prospective study
Irwanto I. et al, (2025), Journal of the International AIDS Society, 28
-
Challenges associated with dapsone for leprosy treatment in Indonesia - urgent need for access to alternative antimicrobial drugs
Krismawati H. et al, (2025), The Lancet Regional Health - Southeast Asia, 34
-
Non-canonical HIV drug resistance mutations: need to close existing gaps.
Inzaule S. et al, (2025), AIDS (London, England)
-
A description of lineage 1 Mycobacterium tuberculosis from papua, Indonesia.
Djunaedy HAK. et al, (2024), Tuberculosis (Edinburgh, Scotland), 149
-
A nationwide mixed-methods study of gaps and barriers to implementation of antimicrobial stewardship programmes in hospitals in Indonesia
Sinto R. et al, (2024), Journal of Hospital Infection, 154, 77 - 87
-
WHO global research priorities for antimicrobial resistance in human health
Bertagnolio S. et al, (2024), The Lancet Microbe, 5, 100902 - 100902
-
Erratum: Development and implementation of a Core Genome Multilocus Sequence Typing (cgMLST) scheme for Haemophilus influenzae
Krisna MA. et al, (2024), Microbial Genomics, 10